Jazz director sells shares after option exercise
Jazz Pharmaceuticals director Rick E. Winningham exercised stock options and sold shares in the company.
Rhea-AI Filing Summary
Jazz Pharmaceuticals director Rick E. Winningham exercised stock options and sold shares in the company. On May 22, 2026, he sold 2,741 Ordinary Shares in an open-market transaction at $241.57 per share, and exercised 3,415 Non-Qualified Stock Options at a $138.08 exercise price.
The options were originally granted in August 2016 and had fully vested by August 1, 2017. Following these transactions, Winningham directly holds 9,567 Ordinary Shares of Jazz Pharmaceuticals, indicating he retained a meaningful equity stake after the exercise-and-sale activity.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Winningham Rick E
Role
Director
Sold
2,741 shs ($662K)
Approx. gross sale proceeds
$662K
Approx. exercise cost
$472K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 3,415 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 3,415 | $138.08 | $472K |
| Sale | Ordinary Shares | 2,741 | $241.57 | $662K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 0 contracts (Direct);
Ordinary Shares — 9,567 shares (Direct)
Footnotes (1)
- F1. This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017.
Key Figures
Shares sold: 2,741 shares
Sale price: $241.57 per share
Options exercised: 3,415 shares
+3 more
6 metrics
Shares sold
2,741 shares
Ordinary Shares sold on May 22, 2026
Sale price
$241.57 per share
Open-market sale of Ordinary Shares
Options exercised
3,415 shares
Non-Qualified Stock Option exercise on May 22, 2026
Option exercise price
$138.08 per share
Exercise price for Non-Qualified Stock Option
Shares held after sale
9,567 shares
Total Ordinary Shares directly held following transactions
Option expiration date
August 10, 2026
Expiration date of exercised Non-Qualified Stock Option
Key Terms
Non-Qualified Stock Option (right to buy), open-market sale, derivative security, vested, +1 more
5 terms
Non-Qualified Stock Option (right to buy) financial
"security_title: "Non-Qualified Stock Option (right to buy)""
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vested financial
"The options were fully vested as of August 1, 2017."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Jazz Pharmaceuticals (JAZZ) director Rick Winningham do in this Form 4 filing?
Rick Winningham reported an option exercise and a related share sale. He exercised 3,415 Non-Qualified Stock Options and sold 2,741 Ordinary Shares on May 22, 2026, reflecting a typical compensation-related transaction while maintaining a direct equity position in Jazz Pharmaceuticals.
What stock options did Rick Winningham exercise in Jazz Pharmaceuticals (JAZZ)?
He exercised 3,415 Non-Qualified Stock Options with a $138.08 exercise price. These options were granted on August 11, 2016 and vested over one year from September 1, 2016, becoming fully vested by August 1, 2017 before being exercised in this transaction.
Were Rick Winningham’s Jazz Pharmaceuticals (JAZZ) option exercises tied to an old grant?
Yes. The Non-Qualified Stock Option exercised for 3,415 shares was granted on August 11, 2016. It vested over one year starting September 1, 2016 and was fully vested as of August 1, 2017, indicating a long-standing compensation award realized in 2026.
What was the exercise price and expiration date of Rick Winningham’s Jazz (JAZZ) stock options?
The exercised Non-Qualified Stock Option had a $138.08 exercise price and an August 10, 2026 expiration date. Exercising 3,415 underlying Ordinary Shares before expiration converted this derivative position into directly held shares, some of which were then sold in the market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
